(Reuters) -Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish ...

Governor Andrew Bailey says the BOE will take a “gradual and careful” approach to cutting rates Join the Markets Today team - ...

London's blue-chip index jumped to a record high on Thursday, lifted by shares of AstraZeneca after upbeat results and ahead ...

The FTSE 100 has started the year with a bang, hitting its second all-time high of 2025 on Thursday morning, surging past ...

New growth and inflation projections are due to be unveiled later alongside the Bank of England’s latest interest rates ...

GSK shares lead the FTSE 100 after it raised its growth guidance and announced a share buyback Join the Markets Today team -- ...

British stocks were set to fall for the third straight session on Wednesday, as a stronger pound put pressure on the ...

UK's FTSE 100 firmed on Wednesday after two straight days of losses, buoyed by gains in shares of heavyweight GSK and gold ...

Explore the factors behind the FTSE 100's record high, including corporate earnings, interest rate expectations, and sector ...

The FTSE 100 and FTSE 250 surged higher today after the Bank of England moved to cut interest rates to 4.5 per cent in a bid ...

While the FTSE 100 powers higher, Wall Street remains contained following its rebound earlier in the week, says Chris ...

Most sectors in the FTSE 100 were up, boosted by strong corporate earnings. AstraZeneca, the FTSE 100’s most valuable company, rose 4.8 per cent following better than expected results. Shares in ...